133 related articles for article (PubMed ID: 31769777)
1. Sgc8 aptamer targeted glutathione-responsive nanoassemblies containing Ara-C prodrug for the treatment of acute lymphoblastic leukemia.
Fang Z; Wang X; Sun Y; Fan R; Liu Z; Guo R; Xie D
Nanoscale; 2019 Dec; 11(47):23000-23012. PubMed ID: 31769777
[TBL] [Abstract][Full Text] [Related]
2. Nanoassemblies from amphiphilic cytarabine prodrug for leukemia targeted therapy.
Liu J; Zhao D; He W; Zhang H; Li Z; Luan Y
J Colloid Interface Sci; 2017 Feb; 487():239-249. PubMed ID: 27776282
[TBL] [Abstract][Full Text] [Related]
3. The synergism of 6-mercaptopurine plus cytosine arabinoside followed by PEG-asparaginase in human leukemia cell lines (CCRF/CEM/0 and (CCRF/CEM/ara-C/7A) is due to increased cellular apoptosis.
Nandy P; Periclou AP; Avramis VI
Anticancer Res; 1998; 18(2A):727-37. PubMed ID: 9615712
[TBL] [Abstract][Full Text] [Related]
4. Vincristine-Loaded and sgc8-Modified Liposome as a Potential Targeted Drug Delivery System for Treating Acute Lymphoblastic Leukemia.
Duan S; Yu Y; Lai C; Wang D; Wang Y; Xue D; Hu Z; Lu X
J Biomed Nanotechnol; 2018 May; 14(5):910-921. PubMed ID: 29883561
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional aptamer-silver conjugates as theragnostic agents for specific cancer cell therapy and fluorescence-enhanced cell imaging.
Li H; Hu H; Zhao Y; Chen X; Li W; Qiang W; Xu D
Anal Chem; 2015 Apr; 87(7):3736-45. PubMed ID: 25686206
[TBL] [Abstract][Full Text] [Related]
6. Rational Design of a New Self-Codelivery System from Redox-Sensitive Camptothecin-Cytarabine Conjugate Assembly for Effectively Synergistic Anticancer Therapy.
He W; Hu X; Jiang W; Liu R; Zhang D; Zhang J; Li Z; Luan Y
Adv Healthc Mater; 2017 Dec; 6(24):. PubMed ID: 29076266
[TBL] [Abstract][Full Text] [Related]
7. Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines.
Ramilo-Torno LV; Avramis VI
Cancer Chemother Pharmacol; 1995; 35(3):191-9. PubMed ID: 7805176
[TBL] [Abstract][Full Text] [Related]
8. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
Taub JW; Huang X; Ge Y; Dutcher JA; Stout ML; Mohammad RM; Ravindranath Y; Matherly LH
Cancer Res; 2000 Nov; 60(22):6421-6. PubMed ID: 11103808
[TBL] [Abstract][Full Text] [Related]
9. Redox-sensitive micelles assembled from amphiphilic mPEG-PCL-SS-DTX conjugates for the delivery of docetaxel.
Zhang H; Wang K; Zhang P; He W; Song A; Luan Y
Colloids Surf B Biointerfaces; 2016 Jun; 142():89-97. PubMed ID: 26938324
[TBL] [Abstract][Full Text] [Related]
10. [Effects of bone marrow stromal cells on the chemotherapeutic sensitivity of acute lymphoblastic leukemia cells].
Wang Y; Han ZX; Zhang JC
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):885-890. PubMed ID: 29262503
[No Abstract] [Full Text] [Related]
11. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
Nandy P; Lien EJ; Avramis VI
Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093
[TBL] [Abstract][Full Text] [Related]
12. A nelarabine-resistant T-lymphoblastic leukemia CCRF-CEM variant cell line is cross-resistant to the purine nucleoside phosphorylase inhibitor forodesine.
Yamauchi T; Uzui K; Nishi R; Tasaki T; Ueda T
Anticancer Res; 2014 Sep; 34(9):4885-92. PubMed ID: 25202070
[TBL] [Abstract][Full Text] [Related]
13. Reduction sensitive hyaluronan-SS-poly(ε-caprolactone) block copolymers as theranostic nanocarriers for tumor diagnosis and treatment.
Yang H; Wang N; Mo L; Wu M; Yang R; Xu X; Huang Y; Lin J; Zhang LM; Jiang X
Mater Sci Eng C Mater Biol Appl; 2019 May; 98():9-18. PubMed ID: 30813097
[TBL] [Abstract][Full Text] [Related]
14. cDNA microarray analysis of altered gene expression in Ara-C-treated leukemia cells.
Takagaki K; Katsuma S; Horio T; Kaminishi Y; Hada Y; Tanaka T; Ohgi T; Yano J
Biochem Biophys Res Commun; 2003 Sep; 309(2):351-8. PubMed ID: 12951057
[TBL] [Abstract][Full Text] [Related]
15. Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.
Avramis IA; Laug WE; Sausville EA; Avramis VI
Cancer Chemother Pharmacol; 2003 Oct; 52(4):307-18. PubMed ID: 12827297
[TBL] [Abstract][Full Text] [Related]
16. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
[TBL] [Abstract][Full Text] [Related]
17. Actively targeted delivery of anticancer drug to tumor cells by redox-responsive star-shaped micelles.
Shi C; Guo X; Qu Q; Tang Z; Wang Y; Zhou S
Biomaterials; 2014 Oct; 35(30):8711-22. PubMed ID: 25002267
[TBL] [Abstract][Full Text] [Related]
18. Silver decahedral nanoparticles-enhanced fluorescence resonance energy transfer sensor for specific cell imaging.
Li H; Hu H; Xu D
Anal Chem; 2015 Apr; 87(7):3826-33. PubMed ID: 25764443
[TBL] [Abstract][Full Text] [Related]
19. Galactose-decorated reduction-sensitive degradable chimaeric polymersomes as a multifunctional nanocarrier to efficiently chaperone apoptotic proteins into hepatoma cells.
Wang X; Sun H; Meng F; Cheng R; Deng C; Zhong Z
Biomacromolecules; 2013 Aug; 14(8):2873-82. PubMed ID: 23815094
[TBL] [Abstract][Full Text] [Related]
20. Gene-expression profiling reveals down-regulation of equilibrative nucleoside transporter 1 (ENT1) in Ara-C-resistant CCRF-CEM-derived cells.
Takagaki K; Katsuma S; Kaminishi Y; Horio T; Nakagawa S; Tanaka T; Ohgi T; Yano J
J Biochem; 2004 Nov; 136(5):733-40. PubMed ID: 15632314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]